ACRP blog

JANUARY 3, 2024

Historically, patient recruitment and retention have been pressing issues within the clinical trial space. Eighty-five percent of trials fail to recruit enough patients, while 80% are delayed due to other factors like participant dropouts. These high rates are influenced by financial, emotional, and logistical barriers to participation, such as geographic location and travel-related costs, which prevent patients from enrolling in trials and accessing life-changing medicine.

Clinical Trials 122

Clinical Trials Clinical Trials Trials Medicine 122

Bio Pharma Dive

JANUARY 2, 2024

A non-addictive pain pill faces its definitive test, while study results in ALS, a rare heart disease and lung cancer could have far-reaching implications.

Clinical Trials 357

Clinical Trials Clinical Trials Trials 357

pharmaphorum

JANUARY 4, 2024

Amplifying the patient voice is essential for the success of clinical trials. Learn why it is crucial for patient engagement, recruitment, and overall trial success, and how it can address challenges such as transportation and financial barriers.

Clinical Trials 128

Clinical Trials Clinical Trials Trials 128

Pharmaceutical Technology

JANUARY 3, 2024

A new report from Novotech delves into the multifaceted landscape of HIV, focusing on its impact, treatment, and global initiatives.

Clinical Trials 295

Clinical Trials Clinical Trials Trials Research 295

Advertisement

Clinical Supply

Antidote

JANUARY 3, 2024

While the primary goal of clinical trials is to help identify potential new treatments that improve people's health and save lives, it's the unfortunate truth that the patient experience is often not prioritized. This discrepancy becomes evident in industry findings, highlighting a substantial disparity between the services patients want from pharmaceutical companies compared to what they actually receive.

Clinical Trials 52

Clinical Trials Clinical Trials Trials 52

pharmaphorum

JANUARY 3, 2024

Explore how GenAI is revolutionising clinical trials by bringing precision and innovation to the development of therapies. Learn how this technology is improving patient outcomes and advancing the field of clinical research.

Clinical Trials 57

Clinical Trials Clinical Trials Trials Clinical Research 57

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 2, 2024

A 57-year-old woman from Wisconsin recently sustained a rather unfortunate injury to her buttock. She had attended the hospital for an MRI ( magnetic resonance imaging) scan and had entered the machine with a concealed firearm. The machine’s powerful magnet caused the gun to discharge.

Clinical Trials 195

Clinical Trials Clinical Trials Clinical Research Trials 195

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 1, 2024

Medical imaging has revolutionized diagnostics with artificial intelligence (AI) providing the unprecedented accuracy for fast detection and personalized patient care. The year 2023 for India’s medtech industry characterized by resilience, innovation, provided push toward enhancing healthcare accessibility and quality amid global health challenges.

Clinical Trials 176

Clinical Trials Clinical Trials Clinical Research Trials 176

Bio Pharma Dive

JANUARY 4, 2024

Moonwalk Biosciences, the latest biotech cofounded by the gene editing scientist, joins other startups aiming to alter gene expression without changing DNA.

Gene Editing 349

Gene Editing Gene Expression DNA Gene 349

Pharmaceutical Technology

JANUARY 5, 2024

AbbVie and Umoja Biopharma partnered for the development of in-situ CAR-T cell therapy candidates for oncology targets.

Development 306

Development 306

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

Pharma Mirror

JANUARY 5, 2024

New Delhi, India – FD-AID, LLC, a distinguished leader in pharmaceutical quality and compliance solutions, proudly announces its entry into the Indian pharmaceutical market. Spearheaded by a former US FDA Investigator and seasoned pharmaceutical executive, FD-AID is uniquely positioned to bring a wealth of expertise and insight to India’s rapidly growing pharmaceutical industry.

Compliance 130

Compliance FDA Compliance Marketing Drugs 130

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 4, 2024

The next time you make yourself a berry smoothie, you might want to hold off on the banana. Sure, this fruit is full of potassium and makes a drink deliciously thick and creamy, but according to researchers from the University of California Davis (UCD), there’s something in bananas that might overpower the antioxidants in berries.

Research 211

Research Clinical Trials Clinical Trials Clinical Research 211

Bio Pharma Dive

JANUARY 4, 2024

The company plans to restructure and will start a new late-stage study testing whether its “off-the-shelf” therapy can boost cure rates when used early on.

309

309

Pharmaceutical Technology

JANUARY 1, 2024

In this issue: Pharma’s efforts to curb Scope 3 emissions, understanding European Pharmaceutical legislation, and looking back at the pharma industry’s performance in 2023.

246

246

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Pharma Mirror

JANUARY 2, 2024

The popularity of at-home DNA testing is soaring in popularity and uses. When someone seeks information about paternity or genetic diseases without visiting a doctor’s chamber or laboratory, the best alternative is the at-home DNA test kit. Unless and until the paternity tests are not for legal cases, at-home test kits are an ideal choice. The question which concerns everyone is, ‘are home DNA test kits accurate?’.

DNA 130

DNA Genetic Disease Genetics 130

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 1, 2024

A drug commonly used to treat type 2 diabetes could also effectively protect against colorectal cancer (CRC), based on a new analysis by researchers in the US. The drug in question is a class of medications known as glucagon-like peptide-1 receptor agonists – more easily referred to as GLP-1 RAs.

Drugs 193

Drugs Research Clinical Trials Clinical Trials 193

Bio Pharma Dive

JANUARY 5, 2024

The clearance is a major shift for the agency, which described its decision as a “first step” in allowing Florida to bulk purchase lower-cost Canadian medicines.

Drugs 300

Drugs Medicine 300

Pharmaceutical Technology

JANUARY 4, 2024

Pfizer Canada has received Health Canada approval for gene therapy Beqvez (fidanacogene elaparvovec) for the treatment of haemophilia B.

Gene Therapy 235

Gene Therapy Gene 235

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

Clinical Research

Rethinking Clinical Trials

JANUARY 2, 2024

The National Institute of Nursing Research (NINR) has published a funding opportunity for research to develop and expand interventions and programs that leverage existing or create new healthcare-community partnerships to address unmet social needs among individuals and families and adverse social determinants of health within communities—especially in populations that experience health disparities.

Nurses 130

Nurses Clinical Trials Clinical Trials Research 130

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 3, 2024

Do you hate salad? It’s OK if you do, there are plenty of foods in the world, and lots of different ways to prepare them.

Clinical Trials 168

Clinical Trials Clinical Trials Clinical Research Trials 168

Bio Pharma Dive

JANUARY 2, 2024

Amgen had its bid for full approval of the cancer drug Lumakras turned back by the agency, which also issued complete response letters to Zealand Pharma and Merck & Co. in December.

Drugs 293

Drugs 293

Pharmaceutical Technology

JANUARY 3, 2024

This collaboration comes six years after the German company Boehringer signed two agreements to develop treatments for NASH.

Development 245

Development 245

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research

Fierce Pharma

JANUARY 2, 2024

On the heels of a major Paxlovid inventory write-off in the United States, many more doses of Pfizer's COVID-fighting antiviral are going to waste overseas. | At the end of November, more than 1.5 million courses of Pfizer’s Paxlovid had expired unused in European countries, analysts at Airfinity said in a new report. The total tally of expired doses in Europe is expected to hit 3.1 million by the end of next month, representing a value of $2.2 billion.

140

140

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 4, 2024

Dharwad District Chemists & Druggists Association (DDCDA) is devising strategies to differentiate their service with improved customer experience. These span attention to details like patient education to manage their medication, ensure fair business practices in pricing and dispensing medicines efficiently among others.

Medicine 146

Medicine Clinical Trials Clinical Trials Clinical Research 146

Bio Pharma Dive

JANUARY 4, 2024

The new program, dubbed LillyDirect, will help patients connect with telehealth providers and deliver medicines like the company’s obesity treatment Zepbound.

Medicine 273

Medicine Drugs 273

Pharmaceutical Technology

JANUARY 3, 2024

Novartis will pay Voyager $100m upfront and up to $1.2bn in milestone-based payments and royalties on net sales.

Gene Therapy 246

Gene Therapy Gene Development Sales 246

Advertisement

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

Clinical Trials

Fierce Pharma

JANUARY 4, 2024

Use of Novo Nordisk and Eli Lilly’s popular diabetes and weight loss drugs come with warnings about a rare intestinal blockage condition called ileus, which can be life threatening. | Use of Novo Nordisk and Eli Lilly’s popular diabetes and weight loss drugs come with warnings about a rare intestinal blockage condition called ileus. Could cautions about more common side effects soon be added to the labels of popular treatments such as Novo’s Ozempic and Lilly’s Mounjaro?

Drugs 133

Drugs Production 133

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 3, 2024

Navigating regulatory affairs in the biopharma industry requires a skilled talent pool, according to Benjamin James, HR Leader, Asia-Pacific, Cytiva Lifesciences – a global life sciences (biopharma) company. He cited Cytiva’s Global Biopharma Resilience Index (GBRI), which reveals a decline in overall talent pool resilience, with the score dropping from 6.27 in 2021 to 5.

HR 130

HR Life Science Clinical Trials Clinical Trials 130

Bio Pharma Dive

JANUARY 5, 2024

Lykos Therapeutics, formerly known as MAPS Public Benefit Corp., recently submitted its MDMA capsules for FDA approval, following two positive studies.

FDA Approval 281

FDA Approval 281

Pharmaceutical Technology

JANUARY 4, 2024

Gene Therapy to Target CD19 and CD22 for Refractory and Relapsed B-cell Acute Lymphoblastic Leukemia is under clinical development by China Immunotech (Beijing) Biotechnology and currently in Phase I for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia).

Gene Therapy 230

Gene Therapy Gene Clinical Development Development 230

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Clinical Trials